Sangamo Therapeutics Inc (NASDAQ:SGMO)

8.53
Delayed Data
As of Feb 28
 +1.86 / +27.98%
Today’s Change
6.43
Today|||52-Week Range
13.91
+1.91%
Year-to-Date
Here's Why Sangamo Therapeutics Jumped Higher Today
Feb 28 / MotleyFool.com - Paid Partner Content
Sangamo Therapeutics and Biogen Announce Gene-Therapy Deal, Stock up 39%
Feb 27 / MotleyFool.com - Paid Partner Content
Sangamo Therapeutics Inc (SGMO) Q4 2019 Earnings Call Transcript
Feb 28 / MotleyFool.com - Paid Partner Content
BioMarin's Novel Treatment Promises to Disrupt Competitors
Feb 26 / MotleyFool.com - Paid Partner Content
Can CRISPR Therapeutics Double Your Money in 2020?
Feb 28 / MotleyFool.com - Paid Partner Content
Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease
Feb 23 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close6.67
Today’s open8.93
Day’s range8.02 - 9.19
Volume10,057,101
Average volume (3 months)1,607,696
Market cap$863.7M
Data as of 02/28/2020

Growth & Valuation

Earnings growth (last year)-0.70%
Earnings growth (this year)-75.36%
Earnings growth (next 5 years)-17.98%
Revenue growth (last year)+130.95%
P/E ratio--
Price/Sales13.18
Price/Book2.08

Competitors

 Today’s
change
Today’s
% change
IMGNImmunoGen Inc+0.06+1.37%
RYTMRhythm Pharmaceutica...+0.92+5.10%
STOKStoke Therapeutics I...+1.96+8.60%
CARACara Therapeutics In...-0.32-2.08%
Data as of 02/28/2020

Financials

Next reporting dateMay 12, 2020
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$84.5M
Annual profit (last year)-$68.3M
Net profit margin-80.91%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Richmond, California

Forecasts